Undervalued Small Caps With Insider Buying

Results

201

32 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

201 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AVIA
Rp328.003.8%-24.1%Rp19.4tRp519.0010.85.9%6.7%Materials
OU8
S$1.580.6%-11.7%S$1.3bS$1.8811.6-0.3%2.5%Real Estate Management and Development
SECB
₱68.402.1%-12.5%₱51.5b₱96.920.314.7%4.4%Banks
BCI
AU$0.443.5%23.9%AU$1.3bAU$0.63338.247.6%0%Materials
KLBF
Rp735.005.0%-48.1%Rp33.3tRp1,245.299.28.3%2.7%Pharmaceuticals & Biotech
PGC
AU$0.13-7.4%-68.8%AU$206.9mAU$0.250.196.0%n/aHealthcare
EW
₱11.70-0.8%-10.0%₱26.3b₱13.700.38.8%5.8%Banks
OCE
R71.930.6%36.5%R8.7bR90.0012.18.3%4.0%Food, Beverage & Tobacco
1837
HK$1.55-5.5%96.2%HK$3.4bHK$2.1611.017.9%4.6%Food, Beverage & Tobacco
AUBN
US$26.18-0.6%-1.9%US$91.7mn/a1.0n/a4.1%Banks
ILPT
US$8.68-4.1%40.6%US$584.0mUS$10.271.38.2%4.6%Real Estate
SMWB
US$7.423.2%0.7%US$637.7mUS$5.802.2112.6%n/aSoftware
NMAN
SEK 132.402.3%-20.3%SEK 4.6bSEK 155.0018.921.7%3.0%Capital Goods
SHBI
New
US$24.620.7%59.3%US$819.3mUS$25.751.38.1%2.3%Banks
KINS
US$20.310.6%28.9%US$292.0mUS$21.509.520.8%1.0%Insurance
RCEL
US$4.640.7%-12.1%US$142.2mUS$9.072.064.1%n/aPharmaceuticals & Biotech
ONT
US$22.8511.6%0.6%US$795.4mUS$27.00186.698.9%n/aCommercial Services
AOMR
US$9.121.7%5.3%US$218.8mUS$10.7512.332.1%14.0%Diversified Financials
NXR.UN
CA$8.04-4.3%4.1%CA$793.2mCA$8.500.53.0%8.0%Real Estate
BOTJ
US$27.10-2.3%94.7%US$123.4mn/a1.5n/a1.5%Banks
CEVI
SEK 148.803.0%-14.0%SEK 3.5bSEK 175.6727.517.8%1.8%Healthcare
ECEL
UK£1.18-1.3%-20.9%UK£114.9mUK£2.0512.031.7%5.4%Capital Goods
SBB B
SEK 3.422.6%-32.7%SEK 6.5bSEK 3.353.281.3%0%Real Estate Management and Development
CBNA
New
US$47.8310.2%77.9%US$310.9mUS$49.001.710.1%n/aBanks
Page 1 of 6